Detalhe da pesquisa
1.
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.
Pharmacoepidemiol Drug Saf
; 31(5): 495-510, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191114
2.
Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients' healthcare in Spain.
Clin Transl Oncol
; 26(6): 1319-1328, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349577
3.
Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study.
Front Pharmacol
; 14: 1118203, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033631
4.
Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom.
Nat Commun
; 13(1): 7167, 2022 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418291
5.
Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency.
Thromb Haemost
; 119(9): 1409-1418, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254973
6.
Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain.
Future Cardiol
; 14(3s): 3-8, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848095
7.
Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.
Thromb Haemost
; 99(2): 443-4, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18278198